Today: 6 June 2026
Browse Category

NYSE:INFQ 23 February 2026 - 3 June 2026

Infleqtion Stock Soared After $100 Million Quantum Move, Eyes Tuesday Event

Infleqtion Stock Soared After $100 Million Quantum Move, Eyes Tuesday Event

Infleqtion Inc. shares rose 11.2% Friday, closing at $16.35 after the U.S. Commerce Department signed a letter of intent for $100 million in planned quantum-computing incentives for the company. The stock is up 31% since May 15. The funding is not final and depends on further approvals and milestones. Infleqtion reported a Q1 operating loss of $33.6 million on $9.5 million in revenue.
24 May 2026
··
Infleqtion shares react to $100 million quantum funding news in Washington

Infleqtion Stock Jumps 31% After $100 Million Quantum Funding Letter — Why the Rally Isn’t Simple

Infleqtion shares jumped 31.5% to $15.99 after hours Thursday following news of a proposed $100 million U.S. quantum-computing award. The NYSE-listed company reported a first-quarter operating loss of $33.6 million on $9.5 million in revenue and raised its 2026 revenue outlook to at least $40 million. The Commerce Department’s program totals $2.013 billion across nine companies.
22 May 2026
·
Infleqtion (INFQ) stock sinks in early trade as tariff jitters bite — what to watch next

Infleqtion (INFQ) stock sinks in early trade as tariff jitters bite — what to watch next

Infleqtion shares dropped about 10% to $11.95 Monday morning, falling below their opening price amid broader market declines tied to new U.S. tariff uncertainty. The quantum technology firm, which debuted last week after merging with Churchill Capital Corp X, saw about 686,000 shares traded by mid-morning. Investors await the company’s March 11 Analyst Day for more detailed guidance.
23 February 2026
·

Stock Market Today

  • WELL Health Technologies Strengthens Leadership Amid Public-Sector Digital Health Push
    June 6, 2026, 12:23 PM EDT. WELL Health Technologies (TSX:WELL) appointed Dr. Andrew Bond as Chief Health Officer and Derek Clark as Chief Operating Officer to bolster clinical governance and operations. These hires support WELL's strategy to deepen engagement with public health systems and expand its digital health network in Canada. The company recently surpassed a CA$100 million annualized Adjusted EBITDA run rate, underscoring reliance on efficient clinic acquisitions. While leadership aims to enhance integration and government partnerships, regulatory risks and concentration in Canada remain challenges. Analysts project WELL's revenue reaching CA$1.8 billion by 2029, with fair value estimates suggesting potential upside of 44%. Investors should weigh these developments against data privacy concerns and execution risks in the evolving digital health landscape.

Latest articles

Energy Transfer Streak Ends; Next Week in Focus

Energy Transfer Streak Ends; Next Week in Focus

6 June 2026
Energy Transfer fell 1.17% to $19.39, snapping a four-day winning streak as U.S. stocks and oil prices dropped sharply, but still gained 1.1% for the week; investors now face uncertainty over CEO succession, commodity price swings, and project spending, with Monday’s session set to test whether Friday’s decline signals a broader turn for midstream energy stocks.
Philippine Airlines adds ex-Malaysia Airlines boss to board as A350 ramp picks up

Philippine Airlines adds ex-Malaysia Airlines boss to board as A350 ramp picks up

6 June 2026
Philippine Airlines appointed ex-Malaysia Aviation Group chief Izham Ismail and former Shell Philippines chair Edgar Chua as independent directors as it expands long-haul routes with new Airbus A350-1000s; the move comes amid rising operating costs, margin pressures, and uncertainty over aircraft deliveries, even as 2025 net income rose 6.1% to $160.4 million on $3.22 billion revenue.
SK Hynix Drops 10% After Hit, Here’s What’s Next for Traders

SK Hynix Drops 10% After Hit, Here’s What’s Next for Traders

6 June 2026
SK hynix plunged 9.92% to 2,070,000 won Friday, capping a 12% five-day slide after a record high, as tech stocks sold off globally and a “sidecar” halt hit Seoul trading; investors now face a key test of confidence in the AI-memory trade, with the stock’s future hinging on HBM demand, U.S. chip sector moves, and details of a planned U.S. ADR listing, which remains under SEC review.
Clorox Shares Gain 5% As Broader Market Drops—What’s Ahead

Clorox Shares Gain 5% As Broader Market Drops—What’s Ahead

6 June 2026
Clorox surged 5.03% to $94.14 Friday, defying a 2.64% S&P 500 drop, as investors sought safety despite CEO-transition risk, weak organic sales guidance, and looming U.S. inflation data; the stock remains 28.7% below its 52-week high after a week marked by management uncertainty and a challenging consumer environment.
Go toTop